NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

Cabaletta Bio Shows Promising Results for Autoimmune Disease Treatment Without Chemotherapy

Cabaletta Bio's rese-cel achieves complete B cell depletion and rapid symptom improvement in pemphigus vulgaris patients without preconditioning.

Cabaletta Bio Shows Promising Results for Autoimmune Disease Treatment Without Chemotherapy
Credit: Cabaletta Bio
Already have an account? Sign in.
10/09/2025 · 12:36 PM
CABA
/ Read more

Feed↓

Morgan Stanley: Memory Selloff is Healthy – Strength Will Last Longer
03/26/2026 · 9:11 AM

Morgan Stanley: Memory Selloff is Healthy – Strength Will Last Longer

Morgan Stanley analyst says the recent drop in memory stocks is a healthy pullback. Memory supply remains the key constraint for AI growth, with strong cash flow expected to drive Micron and other stocks higher.

/ Subscriber only
Kodiak Sciences Stock Surges After Strong Phase 3 Eye Drug Results
03/26/2026 · 8:41 AM

Kodiak Sciences Stock Surges After Strong Phase 3 Eye Drug Results

Kodiak Sciences shares surged after Zenkuda hit its primary endpoint in the GLOW2 Phase 3 study for diabetic retinopathy.

/ Subscriber only
WVE-007 Shows Muscle-Preserving Fat Loss in Early Data, But Weight Reduction Remains Modest
03/26/2026 · 8:16 AM

WVE-007 Shows Muscle-Preserving Fat Loss in Early Data, But Weight Reduction Remains Modest

Wave Life Sciences' WVE-007 (INHBE-targeted) showed ~5% total fat reduction and 14% visceral fat drop with muscle preserved after one dose. Early results are modest (1% weight loss), but support infrequent dosing as potential GLP-1 complement.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe